Submitted by Anonymous (not verified) on 17 November 2026 - 15:10
Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 73, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 73, Status: Authorised